Stocks to watch Friday: Tamboran Resources, Scholastic, Costco, Prime Medicine and INLIF

  • Tamboran Resources, Scholastic, Costco, Prime Medicine and INLIF drew Friday investor attention.
  • Costco reported $6.75 earnings per share and $95.72 billion quarterly revenue.
  • INLIF reported 26.01% net revenue growth, while Prime Medicine received FDA clearance for PM647.

U.S. stock futures traded higher Friday as investors monitored several companies following earnings reports, regulatory developments and expected results. Tamboran Resources was expected to report a quarterly loss of 30 cents per share on revenue of $3.82 million before the opening bell, according to Benzinga Pro data; its shares rose 1.4% to $36.25 Thursday. Scholastic reported a first-quarter loss of $3.63 per share and sales of $216.800 million, missing analyst estimates of a $3.40 loss and $224.689 million in revenue. Its shares fell 12.2% to $30.58 after hours. Costco reported better-than-expected fiscal fourth-quarter 2026 results, with earnings of $6.75 per share and revenue of $95.72 billion, beating estimates of $6.52 and $94.86 billion. Its shares rose 0.2% to $898. Prime Medicine gained 11.7% to $3.43 after the FDA cleared its Investigational New Drug application for PM647 in Alpha-1 antitrypsin deficiency. INLIF reported a 26.01% increase in unaudited first-half fiscal 2026 net revenue to $12.94 million from $10.27 million a year earlier, sending its shares up 93.2% to $5.70 after hours.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.